1. Current Status of PSMA-Targeted Radioligand Therapy in the Era of Radiopharmaceutical Therapy Acquiring Marketing Authorization

   • So Won Oh
   • Minseok Suh
   • Gi Jeong Cheon

   Review 20 August 2022 Pages: 263 - 281

   

2. Preliminary Study for Quantitative Assessment of Sacroiliitis Activity Using Bone SPECT/CT: Comparison of Diagnostic Performance of Quantitative Parameters

   • Koeun Lee
   • Hyunji Kim
   • Jin-Sook Ryu

   Original Article 22 August 2022 Pages: 282 - 290

   

3. The Radiation Dose Absorbed by Healthy Parenchyma Is a Predictor for the Rate of Contralateral Hypertrophy After Unilobar Radioembolization of the Right Liver

   • Nazim Coskun
   • Aslihan Yildirim
   • Elif Ozdemir

   Original Article 31 August 2022 Pages: 291 - 298

   

4. Focal Nasopharyngeal Activity Detected on [¹⁸F]FDG PET/CT: Clinical Implications and Comparison of Metabolic Parameters for Prediction of Malignancy

   • Wai-Chung Wong

   Original Article 10 September 2022 Pages: 299 - 305

   

5. Association of Fluorodeoxyglucose Positron Emission Tomography Radiomics Features with Clinicopathological Factors and Prognosis in Lung Squamous Cell Cancer

   • Mustafa Erol
   • Hasan Önner
   • İlknur Küçükosmanoğlu

   Original Article 23 September 2022 Pages: 306 - 312

   

6. Preparation of Patient Doses of [¹⁷⁷Lu]Lu-DOTATATE and [¹⁷⁷Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) ¹⁷⁷Lu

   • Raviteja Nanabala
   • Maroor Raghavan Ambikalmajan Pillai
   • Buvaneswari Gopal

   Original Article 07 October 2022 Pages: 313 - 322

   

7. Neuroendocrine Tumor of Tailgut Cyst with Unexpected Metastases

   • Gulhan Ipek Deniz
   • Resit Akyel
   • Yersu Kapran

   Case Report 01 October 2022 Pages: 323 - 327

   

8. Extramedullary Hematopoiesis Visualized on FDG-PET/CT in a Patient with Beta-Thalassemia

   • Sara E. Dahlsgaard-Wallenius
   • Karen Juul-Jensen
   • Malene Grubbe Hildebrandt

   Interesting image 20 September 2022 Pages: 328 - 330